Professur für Molekulare Mechanismen der Organfibrose

Reallocation / Closing: 30.09.2022


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology (2019) Butler EA, Baron M, Fogo AB, Frech T, Ghossein C, Hachulla E, Hoa S, et al. Journal article Therapie der systemischen Sklerose-assoziierten interstitiellen Lungenerkrankung (2019) Prasse A, Bonella F, Müller-Ladner U, Witte T, Hunzelmann N, Distler J Journal article, Review article Possible adaptations of vascularised human skin equivalents to include rare cell populations and study fibroblast heterogeneity. Response to: ‘In search for the ideal anatomical composition of vascularised human skin equivalents for systemic sclerosis translational research: should we recruit the telocytes?’ by Manetti and Matucci-Cerinic (2019) Matei AE, Distler J Journal article, Letter Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs (2019) Matei AE, Chen CW, Kiesewetter L, Györfi AH, Li YN, Trinh-Minh T, Xu X, et al. Journal article Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual (2019) Fasano S, Riccardi A, Messiniti V, Caramaschi P, Rosato E, Maurer B, Smith V, et al. Journal article Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases (2019) Fischer A, Distler J Journal article, Review article Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc (2019) Liang R, Kagwiria R, Zehender A, Dees C, Bergmann C, Krasowska D, Michalska-Jakubus M, et al. Journal article Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis–associated interstitial lung disease (2019) Wollin L, Distler J, Denton CP, Gahlemann M Journal article, Review article Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study (2019) Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, et al. Journal article